Pamela J Goodwin Selected Research

Pamela J Goodwin Research Topics

Disease

59	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2002
36	Neoplasms (Cancer) 12/2023 - 01/2002
21	Obesity 11/2021 - 01/2002
9	Insulin Resistance 01/2014 - 11/2005
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2008
5	Weight Loss (Weight Reduction) 01/2022 - 07/2014
5	Inflammation (Inflammations) 01/2020 - 06/2012
4	Body Weight (Weight, Body) 01/2018 - 08/2010
3	Overweight 11/2021 - 08/2013
3	Hyperinsulinism (Hyperinsulinemia) 04/2011 - 04/2009
2	Chronic Disease (Chronic Diseases) 07/2023 - 02/2011
2	Diarrhea 01/2022 - 12/2008
2	Dyslipidemias (Dyslipidemia) 07/2021 - 11/2005
2	Circulating Neoplastic Cells 06/2021 - 04/2018
2	Nausea 12/2010 - 12/2008
2	Constipation 12/2010 - 12/2008
1	Drug-Related Side Effects and Adverse Reactions 07/2023
1	Infections 01/2022
1	COVID-19 01/2022
1	Menstruation Disturbances 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Neoplasm Metastasis (Metastasis) 12/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Weight Gain 07/2017
1	Triple Negative Breast Neoplasms 01/2017
1	Hyperglycemia 04/2011
1	Dizziness (Lightheadedness) 12/2010
1	Hot Flashes 12/2010

Drug/Important Bio-Agent (IBA)

27	Insulin (Novolin)FDA Link 10/2021 - 01/2002
25	Metformin (Glucophage)FDA LinkGeneric 12/2023 - 12/2008
13	Hormones (Hormone)IBA 07/2023 - 11/2002
10	Estrogen ReceptorsIBA 12/2023 - 07/2002
8	Vitamin D FDA LinkGeneric 01/2020 - 05/2009
7	Glucose (Dextrose)FDA LinkGeneric 07/2021 - 04/2009
7	LeptinIBA 01/2020 - 09/2005
6	C-Reactive ProteinIBA 07/2021 - 06/2012
4	Progesterone Receptors (Progesterone Receptor)IBA 12/2023 - 11/2002
4	Estrogens (Estrogen)FDA Link 01/2021 - 01/2015
4	AdipokinesIBA 12/2016 - 06/2012
3	BiguanidesIBA 01/2022 - 12/2008
3	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 11/2018 - 02/2015
3	CholesterolIBA 07/2017 - 11/2005
3	Insulin ReceptorIBA 03/2015 - 11/2007
2	AntigensIBA 10/2021 - 04/2018
2	Tumor Biomarkers (Tumor Markers)IBA 10/2021 - 04/2018
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021 - 12/2016
2	Aromatase InhibitorsIBA 01/2021 - 08/2013
2	CytokinesIBA 01/2015 - 09/2005
2	Aromatase (CYP19)IBA 08/2013 - 09/2005
2	Tamoxifen FDA LinkGeneric 08/2013 - 06/2012
2	Proteins (Proteins, Gene)FDA Link 04/2011 - 11/2002
2	LipidsIBA 04/2009 - 11/2005
1	human ERBB2 proteinIBA 12/2023
1	SolutionsIBA 01/2022
1	AntibodiesIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Viral AntigensIBA 01/2022
1	Mucin-1 (CA 15-3 Antigen)IBA 10/2021
1	MucinsIBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 07/2021
1	IronIBA 12/2020
1	HepcidinsIBA 12/2020
1	RNA (Ribonucleic Acid)IBA 12/2020
1	Peptides (Polypeptides)IBA 12/2020
1	Estrone FDA Link 01/2020
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2020
1	Carcinoembryonic AntigenIBA 04/2018
1	Interleukin-8 (Interleukin 8)IBA 04/2018
1	InterleukinsIBA 04/2018
1	Plasminogen Activator Inhibitor 1IBA 04/2018
1	ErbB Receptors (EGF Receptor)IBA 12/2016
1	Progesterone FDA LinkGeneric 06/2015
1	Organic Cation Transporter 1IBA 03/2015
1	Acetyl-CoA CarboxylaseIBA 03/2015
1	Mitogen-Activated Protein Kinase 3IBA 03/2015
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 03/2015
1	Blood Glucose (Blood Sugar)IBA 03/2015
1	Cytostatic AgentsIBA 02/2015
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2015
1	Janus KinasesIBA 01/2015
1	Biological FactorsIBA 01/2015
1	Letrozole (Femara)FDA LinkGeneric 07/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2014
1	Calcitriol (Calcijex)FDA LinkGeneric 10/2013
1	Anastrozole (Arimidex)FDA LinkGeneric 08/2013
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 10/2012
1	Phytoestrogens (Phytoestrogen)IBA 01/2012
1	TOR Serine-Threonine KinasesIBA 04/2011

Therapy/Procedure

18	Therapeutics 07/2023 - 03/2002
4	Drug Therapy (Chemotherapy) 12/2019 - 03/2002
3	Adjuvant Chemotherapy 10/2021 - 07/2014
2	Caloric Restriction 01/2022 - 01/2017
2	Chemoprevention 10/2011 - 06/2011
1	Polypharmacy 07/2023
1	Continuity of Patient Care 01/2018
1	Biological Therapy 12/2016
1	Aftercare (After-Treatment) 03/2015
1	Obesity Management 01/2015
1	Duration of Therapy 10/2013